Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

IPO Review - Krishna Institute of Medical Sciences Ltd - ICICI Direct

Posted On: 2021-06-16 15:06:11 (Time Zone: UTC)


Started by renowned cardiothoracic surgeon Dr Bhaskara Rao Bollineni in 2000, Krishna Institute of Medical Sciences (KIMS) is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana. As of FY21, KIMS operates nine multi-specialty hospitals with a bed capacity of 3,064, including over 2,500 operational beds. It offers a comprehensive range of healthcare services across 25 specialties and super specialties. The company has a strategic focus on the southern India healthcare market where it has a strong understanding of regional nuances, customer culture and the mindset of medical professionals and where there is significant and growing need for quality and affordable healthcare services. In FY21, KIMS recorded ARPOB of Rs. 20,609, a bed occupancy rate of 78.60% and an ALOS of 5.53 days, on an aggregate basis.

Investment Rationale

Strong hospital chain pedigree in AP, Telangana

KIMS owns one of the largest hospital chains in AP and Telangana. It reported Rs. 1340.1 crore of revenues and Rs. 381.0 crore of adjusted EBITDA in FY21, the highest in AP and Telangana. It has 3,064 beds as of 9MFY21, which is 2.2x more beds than the second largest provider in these regions.

Strong financial track record

KIMS has achieved healthy profitability in both Tier I and Tier II, III markets by identifying markets with significant underserved healthcare demand and delivering quality healthcare services at affordable prices, which, in turn, drives patient volumes. As of FY21, KIMS' debt-to-adjusted EBITDA ratio was 0.71x and gearing ratio was 0.31x compared to industry range of 0.1-5.2x. It has achieved strong free cash flow by effectively managing capex. KIMS is one of only three hospitals in India that are rated AA by Crisil.

For details, click on the link below: Link to the report


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.


Other Headlines:

Q1FY22 Result Update - Syngene International - ICICI Direct

Sterlite Technologies - Q1FY22 First Cut - ICICI Direct

Bajaj Auto - Q1FY22 First Cut - ICICI Direct

UltraTech Cement - Q1FY22 First Cut - ICICI Direct

HUL - Q1FY22 First Cut - ICICI Direct

Q1FY22 Result Update - Bajaj Finserv - ICICI Direct

Hindustan Zinc - Q1FY22 First Cut - ICICI Direct

Q1FY22 Analyst Meet - Company Update - Avenue Supermarts - ICICI Direct

Q1FY22 Result Update - Indian Bank - ICICI Direct

FY2020-21 AGM Update - Trent Ltd - ICICI Direct

Q1FY22 Result Update - Supreme Industries - ICICI Direct

Indian Energy Exchange - Q1FY22 First Cut - ICICI Direct

CSB Bank - Q1FY22 First Cut - ICICI Direct

Hindustan Unilever - Q1FY22RU - First cut - YES SECURITIES

Asian Paints Report - Demand rebound strong; profitability, not so much! - HDFC Securities

Maintain ADD on Supreme Industries - Demand recovery to make up for Q1 loss - HDFC Securities

Maintain REDUCE on Jubilant FoodWorks - No fireworks to sustain expensive valuation - HDFC Securities

Mahindra CIE Automotive - Continues to walk the talk - ICICI Securities

Jubilant Foodworks - Capitalizing on the opportunity (per our expectations) - accelerated store expansion - ICICI Securities

Equitas Small Finance Bank - Focus on building stable, scalable bank with prudent and conservative approach - ICICI Securities

CEAT - Challenging quarter amidst rising input costs - ICICI Securities

Havells India - Likely market shares gains across segments - ICICI Securities

I-direct Instinct - PPAP Automotive - ICICI Direct

Consumer Durables Sector Update Report - Inspiring recovery; rich valuation to sustain - HDFC Securities

CEAT - Q1 FY22 first cut - YES Securities

Havells India - Q1 FY22 first cut - YES Securities

Polycab India - Q1 FY22 first cut - YES Securities

Jubilant Foodworks - Q1 FY22 results and investor call takeaways - YES Securities

Asian Paints - Q1 FY22 results and investor call takeaways - YES Securities

Bajaj Finance - Q1 FY22 Result Report - YES Securities

CRISIL Ltd - Q2 CY21 Result Report - YES Securities

HCL Technologies - Q1 FY22 Result Report - YES Securities

Gland Pharma - Q1 FY22 Result Report - YES Securities

ICICI Prudential Life - Q1 FY22 Result Report - YES Securities

Syngene International - Q1 FY22 Result Report - YES Securities

Q1FY22 Company Update - GTPL Hathway - ICICI Direct

Supreme Industries - Q1FY22 First Cut - ICICI Direct

Bajaj Finserv - Q1FY22 First Cut - ICICI Direct

Polycab India - Q1FY22 First Cut - ICICI Direct

Rallis India - Q1FY22 First Cut - ICICI Direct

Q1FY22 Result Update - Asian Paints - ICICI Direct

Gladiator Stocks - Kansai Nerolac Paints - ICICI Direct

Q1FY22 Result Update - Nippon Life India AMC - ICICI Direct

Q1FY22 Result Update - Bajaj Finance - ICICI Direct

Q1FY22 Company Update - Mastek Ltd - ICICI Direct

ICICI Prudential Life - Strong performance in tough times - HDFC Securities

Maintain REDUCE on Bajaj Finance - Speed bumps to a fast recovery - HDFC Securities

Maintain BUY on Mastek - Strong growth engine - HDFC Securities

First cut and detailed views on Asian Paints Q1FY22 Results - YES SECURITIES

Larsen & Toubro Infotech - Margin trajectory will be the key - ICICI Securities


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020